This blog entry has abbreviated/summarized this presentation. Though not intentional, some important material is likely to have been omitted; in addition, transcription errors are possible as well.
Slides from syllabus: APGNN Syllabus 2017
Key points:
- ~30% of pediatric IBD patients have anxiety or depression. This has not been shown to be related to disease activity.
- Advice for parents: “Listen more and talk less.”
- Antidepressants, when indicated, are about 6 times more likely to be helpful than detrimental
In the following slide, the term “normalize” indicates that checking on emotional health is part of a routine (eg. ‘we ask all our patients to complete this screening’)












Pingback: IBD Update March 2019 | gutsandgrowth
Pingback: Antidepressants for Patients with IBD and Their (Beneficial) Affect on Bowel Disease Activity | gutsandgrowth